Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy.
PURPOSE:Intermittent androgen deprivation therapy is an effective treatment for metastatic prostate cancer. However, no study to date has evaluated the long-term outcomes of this treatment among patients with prostate cancer after radical prostatectomy. We retrospectively examined the treatment outc...
Main Authors: | Shintaro Maru, Hideki Uchino, Takahiro Osawa, Satoshi Chiba, Gaku Mouri, Ataru Sazawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5967753?pdf=render |
Similar Items
-
Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
by: Naoko Akitake, et al.
Published: (2018-09-01) -
Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
by: Liu J, et al.
Published: (2013-06-01) -
Long-Term Renal Function Outcomes in Bladder Cancer After Radical Cystectomy
by: Takahiro Osawa, et al.
Published: (2013-03-01) -
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
by: Per-Anders Abrahamsson
Published: (2017-10-01) -
Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
by: Yamamoto Y, et al.
Published: (2016-12-01)